These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 37494554)

  • 1. Diet and Gut Inflammation: The Effect of Diet on Inflammatory Markers in Inflammatory Bowel Disease - A Scoping Review.
    Sabo CM; Simiras C; Ismaiel A; Dumitrascu DL
    J Gastrointestin Liver Dis; 2023 Sep; 32(3):402-410. PubMed ID: 37494554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary interventions for induction and maintenance of remission in inflammatory bowel disease.
    Limketkai BN; Iheozor-Ejiofor Z; Gjuladin-Hellon T; Parian A; Matarese LE; Bracewell K; MacDonald JK; Gordon M; Mullin GE
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD012839. PubMed ID: 30736095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal calprotectin and its correlation with inflammatory markers and endoscopy in patients from India with inflammatory bowel disease.
    Samant H; Desai D; Abraham P; Joshi A; Gupta T; Dherai A; Ashavaid T
    Indian J Gastroenterol; 2015 Nov; 34(6):431-5. PubMed ID: 26589229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China.
    Chen JM; Liu T; Gao S; Tong XD; Deng FH; Nie B
    World J Gastroenterol; 2017 Dec; 23(46):8235-8247. PubMed ID: 29290660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enteral Nutrition in Patients with Inflammatory Bowel Disease. Systematic Review, Meta-Analysis, and Meta-Regression.
    Comeche JM; Caballero P; Gutierrez-Hervas A; García-Sanjuan S; Comino I; Altavilla C; Tuells J
    Nutrients; 2019 Nov; 11(11):. PubMed ID: 31689999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enteral nutritional therapy for induction of remission in Crohn's disease.
    Zachos M; Tondeur M; Griffiths AM
    Cochrane Database Syst Rev; 2007 Jan; (1):CD000542. PubMed ID: 17253452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visceral adiposity and inflammatory bowel disease.
    Rowan CR; McManus J; Boland K; O'Toole A
    Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
    Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
    Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predefined Diets in Patients with Inflammatory Bowel Disease: Systematic Review and Meta-Analysis.
    Comeche JM; Gutierrez-Hervás A; Tuells J; Altavilla C; Caballero P
    Nutrients; 2020 Dec; 13(1):. PubMed ID: 33375314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabis for the treatment of Crohn's disease.
    Kafil TS; Nguyen TM; MacDonald JK; Chande N
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012853. PubMed ID: 30407616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic accuracy of fecal calprotectin in assessing the severity of inflammatory bowel disease: From laboratory to clinic.
    Moein S; Qujeq D; Vaghari Tabari M; Kashifard M; Hajian-Tilaki K
    Caspian J Intern Med; 2017; 8(3):178-182. PubMed ID: 28932369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enteral nutrition for maintenance of remission in Crohn's disease.
    Akobeng AK; Zhang D; Gordon M; MacDonald JK
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD005984. PubMed ID: 30098021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine Deaminase as a Useful Biomarker for Diagnosis and Monitoring of Inflammatory Bowel Disease.
    Yordanova M; Gerova D; Atanassova A; Galunska B
    Clin Lab; 2020 Jul; 66(7):. PubMed ID: 32658411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diet as a Trigger or Therapy for Inflammatory Bowel Diseases.
    Lewis JD; Abreu MT
    Gastroenterology; 2017 Feb; 152(2):398-414.e6. PubMed ID: 27793606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effects of increasing omega-3, omega-6 and total polyunsaturated fats on inflammatory bowel disease and markers of inflammation: a systematic review and meta-analysis of randomized controlled trials.
    Ajabnoor SM; Thorpe G; Abdelhamid A; Hooper L
    Eur J Nutr; 2021 Aug; 60(5):2293-2316. PubMed ID: 33084958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enteral nutritional therapy for inducing remission of Crohn's disease.
    Zachos M; Tondeur M; Griffiths AM
    Cochrane Database Syst Rev; 2001; (3):CD000542. PubMed ID: 11686966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid fecal calprotectin level assessment and the SIBDQ score can accurately detect active mucosal inflammation in IBD patients in clinical remission: a prospective study.
    Voiosu T; Benguş A; Dinu R; Voiosu AM; Bălănescu P; Băicuş C; Diculescu M; Voiosu R; Mateescu B
    J Gastrointestin Liver Dis; 2014 Sep; 23(3):273-8. PubMed ID: 25267955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limitations of fecal calprotectin at diagnosis in untreated pediatric Crohn's disease.
    Shaoul R; Sladek M; Turner D; Paeregaard A; Veres G; Wauters GV; Escher J; Dias JA; Lionetti P; Staino A; Kolho KL; de Ridder L; Nuti F; Cucchiara S; Sheva O; Levine A;
    Inflamm Bowel Dis; 2012 Aug; 18(8):1493-7. PubMed ID: 22275268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4+ immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity.
    Brandhorst G; Weigand S; Eberle C; Raddatz D; Karaus M; Oellerich M; Walson PD
    Clin Chim Acta; 2013 Jun; 421():31-3. PubMed ID: 23485644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.